Moreover, RNF43 is recurrently mutated in several cancer types, and RNF43 mutations can promote the initiation and development of human malignancies, such as gastrointestinal cancers, hepatocellular carcinoma, and pancreatic adenocarcinoma [9–11]. This evidence concerns the gene RNF43 and pancreatic adenocarcinoma.